Clinical Trial Update: Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating low-dose corticosteroids as adjuvant therapy for severe H1N1 influenza pneumonia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Pneumonia

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: University of Versailles | Conditions: Pneumonia, Viral, Influenza in Humans | Phase 3 | Status: TERMINATED